Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$144.13 USD
-1.50 (-1.03%)
Updated Aug 7, 2024 03:59 PM ET
After-Market: $144.02 -0.11 (-0.08%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth A Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 10/29/24 |
---|---|
Current Quarter | 1.45 |
EPS Last Quarter | 0.63 |
Last EPS Surprise | -45.22% |
ABR | 1.46 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 4.29 |
Next Year | 6.98 |
EPS (TTM) | 3.31 |
P/E (F1) | 33.94 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 596.55M | 622.63M | 2.32B | 2.72B |
# of Estimates | 9 | 9 | 10 | 10 |
High Estimate | 607.59M | 640.03M | 2.37B | 2.86B |
Low Estimate | 564.17M | 599.28M | 2.22B | 2.49B |
Year ago Sales | 498.80M | 515.20M | 1.89B | 2.32B |
Year over Year Growth Est. | 19.60% | 20.85% | 23.16% | 17.08% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.48 | 1.61 | 4.19 | 7.07 |
# of Estimates | 10 | 8 | 8 | 10 |
Most Recent Consensus | 1.54 | 1.72 | 4.30 | 7.47 |
High Estimate | 1.76 | 1.84 | 4.65 | 8.45 |
Low Estimate | 1.21 | 1.35 | 3.68 | 5.37 |
Year ago EPS | 0.82 | 1.44 | 2.47 | 4.19 |
Year over Year Growth Est. | 80.49% | 11.81% | 69.64% | 68.64% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 6 | 3 | 2 | 4 |
Up Last 30 Days | 8 | 5 | 5 | 6 |
Up Last 60 Days | 8 | 5 | 5 | 6 |
Down Last 7 Days | 0 | 0 | 2 | 1 |
Down Last 30 Days | 0 | 0 | 2 | 1 |
Down Last 60 Days | 0 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 1.45 | 1.49 | 4.29 | 6.98 |
7 Days Ago | 1.31 | 1.37 | 4.22 | 6.73 |
30 Days Ago | 1.30 | 1.31 | 4.03 | 6.69 |
60 Days Ago | 1.30 | 1.31 | 4.03 | 6.69 |
90 Days Ago | 1.29 | 1.30 | 4.02 | 6.51 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 1.45 | 1.57 | 4.36 | 7.38 |
Zacks Consensus Estimate | 1.45 | 1.49 | 4.29 | 6.98 |
Earnings ESP | 0.00% | 5.41% | 1.67% | 5.71% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.63 | 0.42 | 1.44 | 0.82 | NA |
Estimate | 1.15 | 1.04 | 1.13 | 0.91 | NA |
Difference | -0.52 | -0.62 | 0.31 | -0.09 | -0.23 |
Surprise | -45.22% | -59.62% | 27.43% | -9.89% | -21.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more